Fibroblast Growth Factor 23 Expression Is Increased in Multiple Organs in Mice With Folic Acid-Induced Acute Kidney Injury.

Daniela Egli-Spichtig,Martin Y H Zhang,Farzana Perwad

doi:10.3389/fphys.2018.01494

Daniela Egli-Spichtig, Martin Y H Zhang + Show 1 more

Open Access

https://doi.org/10.3389/fphys.2018.01494

Copy DOI

Abstract

Fibroblast growth factor 23 (FGF23) regulates phosphate homeostasis and vitamin D metabolism. In patients with acute kidney injury (AKI), FGF23 levels rise rapidly after onset of AKI and are associated with AKI progression and increased mortality. In mouse models of AKI, excessive rise in FGF23 levels is accompanied by a moderate increase in FGF23 expression in bone. We examined the folic acid-induced AKI (FA-AKI) mouse model to determine whether other organs contribute to the increase in plasma FGF23 and assessed the vitamin D axis as a possible trigger for increased Fgf23 gene expression. Twenty-four hours after initiation of FA-AKI, plasma intact FGF23 and 1,25(OH)2D were increased and kidney function declined. FA-treated mice developed renal inflammation as shown by increased Tnf and Tgfb mRNA expression. Fgf23 mRNA expression was 5- to 15-fold upregulated in thymus, spleen and heart of FA-treated mice, respectively, but only 2-fold in bone. Ectopic renal Fgf23 mRNA expression was also detected in FA-AKI mice. Plasma FGF23 and Fgf23 mRNA expression in thymus, spleen, heart, and bone strongly correlated with renal Tnf mRNA expression. Furthermore, Vdr mRNA expression was upregulated in spleen, thymus and heart and strongly correlated with Fgf23 mRNA expression in the same organ. In conclusion, the rapid rise in plasma FGF23 in FA-AKI mice is accompanied by increased Fgf23 mRNA expression in multiple organs and increased Vdr expression in extra osseous tissues together with increased plasma 1,25(OH)2D and inflammation may trigger the rise in FGF23 in FA-AKI.

Highlights

Fibroblast growth factor 23 (FGF23) is a potent regulator of phosphate homeostasis and vitamin D metabolism (Shimada et al, 2004)
In patients with acute kidney injury (AKI), higher FGF23 levels are associated with AKI progression and increased mortality but mechanisms by which circulating FGF23 increase with kidney injury are unknown (Leaf et al, 2013, 2016, 2017)
In the folic acid-induced AKI (FA-AKI) mouse model, increased Fgf23 mRNA in bone was shown to contribute to the increase in plasma FGF23 (Christov et al, 2013)

Summary

Introduction

Fibroblast growth factor 23 (FGF23) is a potent regulator of phosphate homeostasis and vitamin D metabolism (Shimada et al, 2004). FGF23 inhibits phosphate reabsorption and suppresses 1,25-dihydroxyvitamin D (1,25(OH)2D) production by downregulation of Cyp27b1 and upregulation of Cyp24a1 gene expression (Shimada et al, 2004; Perwad et al, 2007). In pediatric and adult patients with AKI following cardiac surgery, there is a transient increase in plasma intact FGF23 (iFGF23) levels which subsequently normalize (Hanudel et al, 2016; Leaf et al, 2016). Preoperative plasma cFGF23 levels in pediatric and adult patients undergoing cardiac surgery are associated with increased risk of AKI and postoperative mortality (Speer et al, 2015; Hanudel et al, 2016). Pre- and post-operative cFGF23 levels serve as prognostic tools to predict post-operative AKI severity and complications (Speer et al, 2015; Leaf et al, 2016), the mechanisms by which FGF23 levels increase in AKI are poorly understood

Methods

Results

Conclusion